![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
A comparison of currently available direct acting antiviral HCV therapy in Canada - On the path to elimination
|
|
|
Reported by Jules Levin
International Liver Congress (EASL), 10-14 April 2019, Vienna, Austria
A. ALIMOHAMMADI1, J. HOLEKSA1, T. MAGEL1, D. TRUONG1, A. THIAM1, R. YUNG1, L. CHU1, B. CONWAY1
1 Vancouver Infectious Diseases Centre, Vancouver, Canada
![0508191](../images/050819/050819-2/0508191.gif)
![0508192](../images/050819/050819-2/0508192.gif)
![0508193](../images/050819/050819-2/0508193.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|